News Torx® Software announces global drug discovery collaboration with CDD Vault® Sep 13, 2023 Posted by Cresset
News RS Oncology Announces Completion of First-in-Human Phase 1 Clinical Trial of RSO-021, a Novel Irreversible Inhibitor of Mitochondrial PRX3 Sep 12, 2023 Posted by RS Oncology LLC
News BioIVT Completes XenoTech Integration, Highlights Expanded ADME-Tox Research Services at the North American ISSX Meeting Sep 07, 2023 Posted by BioIVT
Case Studies Expedite Training, Technical Support, and Lab Design by Leveraging Mixed Reality Sep 06, 2023
News Skeletal editing and removing the gap between CADD/AIDD and synthesis Sep 05, 2023 Posted by Cresset